Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Arranz

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 15, 2010
Prior use of the neutral red assay and reduction of total protein determination in 96-well plate assaysM J Arranz, M F Festing
Molecular Psychiatry|June 6, 2007
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of researchM J Arranz, J de Leon
Annals of Medicine|April 15, 2000
Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatmentM J Arranz, R W Kerwin
Toxicology|September 27, 2003
Advances in the pharmacogenetic prediction of antipsychotic responseM J Arranz, R W Kerwin
International Journal of Molecular Medicine|December 15, 2000
Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review))M J Arranz, D Mancama, R W Kerwin
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|August 14, 2002
Pharmacogenetics for the individualization of psychiatric treatmentM J Arranz, D Collier, R W Kerwin
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 23, 2003
Reduced expression of the muscarinic 1 receptor cortical subtype in schizophreniaD Mancama, M J Arranz, S Landau, et al.
Expert Review of Molecular Diagnostics|March 21, 2002
Genetic strategies for the personalization of antipsychotic treatmentR W Kerwin, D T Mancama, M J Arranz
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 16, 2007
Choline acetyltransferase variants and their influence in schizophrenia and olanzapine responseD Mancama, I Mata, R W Kerwin, et al.
International Review of Psychiatry (Abingdon, England)|October 1, 2005
Pharmacogenomics--can genetics help in the care of psychiatric patients?A A Bolonna, M J Arranz, D Mancama, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 15, 2010
Prior use of the neutral red assay and reduction of total protein determination in 96-well plate assaysM J Arranz, M F Festing
Molecular Psychiatry|June 6, 2007
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of researchM J Arranz, J de Leon
Annals of Medicine|April 15, 2000
Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatmentM J Arranz, R W Kerwin
Toxicology|September 27, 2003
Advances in the pharmacogenetic prediction of antipsychotic responseM J Arranz, R W Kerwin
International Journal of Molecular Medicine|December 15, 2000
Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review))M J Arranz, D Mancama, R W Kerwin
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|August 14, 2002
Pharmacogenetics for the individualization of psychiatric treatmentM J Arranz, D Collier, R W Kerwin
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 23, 2003
Reduced expression of the muscarinic 1 receptor cortical subtype in schizophreniaD Mancama, M J Arranz, S Landau, et al.
Expert Review of Molecular Diagnostics|March 21, 2002
Genetic strategies for the personalization of antipsychotic treatmentR W Kerwin, D T Mancama, M J Arranz
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 16, 2007
Choline acetyltransferase variants and their influence in schizophrenia and olanzapine responseD Mancama, I Mata, R W Kerwin, et al.
International Review of Psychiatry (Abingdon, England)|October 1, 2005
Pharmacogenomics--can genetics help in the care of psychiatric patients?A A Bolonna, M J Arranz, D Mancama, et al.
Pageof 7